Seqirus UK Limited, a prominent player in the biopharmaceutical industry, is headquartered in Great Britain. Established as a subsidiary of CSL Limited, Seqirus focuses on the development and distribution of innovative vaccines and immunotherapy solutions. With a strong presence in Europe and North America, the company has made significant strides since its founding in 2015, particularly in the field of influenza vaccines. Seqirus is renowned for its unique product offerings, including the adjuvanted flu vaccine, which enhances immune response, setting it apart in a competitive market. The company has achieved notable milestones, such as being one of the largest influenza vaccine manufacturers globally. With a commitment to public health and a robust pipeline of vaccine candidates, Seqirus continues to solidify its position as a leader in the vaccine industry.
We don't have data for Seqirus UK Limited, but we can show you information about their parent organization instead.
View parent company